Click for best price
GeneDeleted Vaccines Market Size, Share 2023
A Gene Deletion Vaccine is a vaccine developed without the ability to replicate by deleting important genes.These substances are very harmless because they cannot be released into the environment.Another benefit of live vaccines is that they can often be delivered via the mucosal route, which is a natural route of infection, thereby inducing mucosal immunity through systemic immunity.By increasing mucosal immunity, disease progression can be halted at the onset of infection.
This report aims to provide a comprehensive presentation of the global market for Gene-Deleted Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene-Deleted Vaccines. This report contains market size and forecasts of Gene-Deleted Vaccines in global, including the following market information:
Global Gene-Deleted Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gene-Deleted Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Single Gene Deleted Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gene-Deleted Vaccines include Virbac SA, Merck Animal Health, Zoetis Inc, Boehringer Ingelheim GmbH, Ceva, Bayer, Biogenesis-Bago, Indian Immunologicals Ltd and Heska Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene-Deleted Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene-Deleted Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gene-Deleted Vaccines Market Segment Percentages, by Type, 2022 (%)
Single Gene Deleted Vaccine
Double Gene Deleted Vaccine
Global Gene-Deleted Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gene-Deleted Vaccines Market Segment Percentages, by Application, 2022 (%)
Veterinary Hospitals
Veterinary Clinics
Animal Care Centers
Others
Global Gene-Deleted Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gene-Deleted Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene-Deleted Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene-Deleted Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Virbac SA
Merck Animal Health
Zoetis Inc
Boehringer Ingelheim GmbH
Ceva
Bayer
Biogenesis-Bago
Indian Immunologicals Ltd
Heska Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene-Deleted Vaccines, market overview.
Chapter 2: Global Gene-Deleted Vaccines market size in revenue.
Chapter 3: Detailed analysis of Gene-Deleted Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene-Deleted Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Gene-Deleted Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene-Deleted Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene-Deleted Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene-Deleted Vaccines Overall Market Size
2.1 Global Gene-Deleted Vaccines Market Size: 2022 VS 2029
2.2 Global Gene-Deleted Vaccines Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene-Deleted Vaccines Players in Global Market
3.2 Top Global Gene-Deleted Vaccines Companies Ranked by Revenue
3.3 Global Gene-Deleted Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Gene-Deleted Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene-Deleted Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene-Deleted Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Gene-Deleted Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene-Deleted Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene-Deleted Vaccines Market Size Markets, 2022 & 2029
4.1.2 Single Gene Deleted Vaccine
4.1.3 Double Gene Deleted Vaccine
4.2 By Type - Global Gene-Deleted Vaccines Revenue & Forecasts
4.2.1 By Type - Global Gene-Deleted Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Gene-Deleted Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Gene-Deleted Vaccines Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene-Deleted Vaccines Market Size, 2022 & 2029
5.1.2 Veterinary Hospitals
5.1.3 Veterinary Clinics
5.1.4 Animal Care Centers
5.1.5 Others
5.2 By Application - Global Gene-Deleted Vaccines Revenue & Forecasts
5.2.1 By Application - Global Gene-Deleted Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Gene-Deleted Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Gene-Deleted Vaccines Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gene-Deleted Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Gene-Deleted Vaccines Revenue & Forecasts
6.2.1 By Region - Global Gene-Deleted Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Gene-Deleted Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Gene-Deleted Vaccines Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gene-Deleted Vaccines Revenue, 2018-2029
6.3.2 US Gene-Deleted Vaccines Market Size, 2018-2029
6.3.3 Canada Gene-Deleted Vaccines Market Size, 2018-2029
6.3.4 Mexico Gene-Deleted Vaccines Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gene-Deleted Vaccines Revenue, 2018-2029
6.4.2 Germany Gene-Deleted Vaccines Market Size, 2018-2029
6.4.3 France Gene-Deleted Vaccines Market Size, 2018-2029
6.4.4 U.K. Gene-Deleted Vaccines Market Size, 2018-2029
6.4.5 Italy Gene-Deleted Vaccines Market Size, 2018-2029
6.4.6 Russia Gene-Deleted Vaccines Market Size, 2018-2029
6.4.7 Nordic Countries Gene-Deleted Vaccines Market Size, 2018-2029
6.4.8 Benelux Gene-Deleted Vaccines Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gene-Deleted Vaccines Revenue, 2018-2029
6.5.2 China Gene-Deleted Vaccines Market Size, 2018-2029
6.5.3 Japan Gene-Deleted Vaccines Market Size, 2018-2029
6.5.4 South Korea Gene-Deleted Vaccines Market Size, 2018-2029
6.5.5 Southeast Asia Gene-Deleted Vaccines Market Size, 2018-2029
6.5.6 India Gene-Deleted Vaccines Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gene-Deleted Vaccines Revenue, 2018-2029
6.6.2 Brazil Gene-Deleted Vaccines Market Size, 2018-2029
6.6.3 Argentina Gene-Deleted Vaccines Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene-Deleted Vaccines Revenue, 2018-2029
6.7.2 Turkey Gene-Deleted Vaccines Market Size, 2018-2029
6.7.3 Israel Gene-Deleted Vaccines Market Size, 2018-2029
6.7.4 Saudi Arabia Gene-Deleted Vaccines Market Size, 2018-2029
6.7.5 UAE Gene-Deleted Vaccines Market Size, 2018-2029
7 Gene-Deleted Vaccines Companies Profiles
7.1 Virbac SA
7.1.1 Virbac SA Company Summary
7.1.2 Virbac SA Business Overview
7.1.3 Virbac SA Gene-Deleted Vaccines Major Product Offerings
7.1.4 Virbac SA Gene-Deleted Vaccines Revenue in Global Market (2018-2023)
7.1.5 Virbac SA Key News & Latest Developments
7.2 Merck Animal Health
7.2.1 Merck Animal Health Company Summary
7.2.2 Merck Animal Health Business Overview
7.2.3 Merck Animal Health Gene-Deleted Vaccines Major Product Offerings
7.2.4 Merck Animal Health Gene-Deleted Vaccines Revenue in Global Market (2018-2023)
7.2.5 Merck Animal Health Key News & Latest Developments
7.3 Zoetis Inc
7.3.1 Zoetis Inc Company Summary
7.3.2 Zoetis Inc Business Overview
7.3.3 Zoetis Inc Gene-Deleted Vaccines Major Product Offerings
7.3.4 Zoetis Inc Gene-Deleted Vaccines Revenue in Global Market (2018-2023)
7.3.5 Zoetis Inc Key News & Latest Developments
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH Company Summary
7.4.2 Boehringer Ingelheim GmbH Business Overview
7.4.3 Boehringer Ingelheim GmbH Gene-Deleted Vaccines Major Product Offerings
7.4.4 Boehringer Ingelheim GmbH Gene-Deleted Vaccines Revenue in Global Market (2018-2023)
7.4.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.5 Ceva
7.5.1 Ceva Company Summary
7.5.2 Ceva Business Overview
7.5.3 Ceva Gene-Deleted Vaccines Major Product Offerings
7.5.4 Ceva Gene-Deleted Vaccines Revenue in Global Market (2018-2023)
7.5.5 Ceva Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Gene-Deleted Vaccines Major Product Offerings
7.6.4 Bayer Gene-Deleted Vaccines Revenue in Global Market (2018-2023)
7.6.5 Bayer Key News & Latest Developments
7.7 Biogenesis-Bago
7.7.1 Biogenesis-Bago Company Summary
7.7.2 Biogenesis-Bago Business Overview
7.7.3 Biogenesis-Bago Gene-Deleted Vaccines Major Product Offerings
7.7.4 Biogenesis-Bago Gene-Deleted Vaccines Revenue in Global Market (2018-2023)
7.7.5 Biogenesis-Bago Key News & Latest Developments
7.8 Indian Immunologicals Ltd
7.8.1 Indian Immunologicals Ltd Company Summary
7.8.2 Indian Immunologicals Ltd Business Overview
7.8.3 Indian Immunologicals Ltd Gene-Deleted Vaccines Major Product Offerings
7.8.4 Indian Immunologicals Ltd Gene-Deleted Vaccines Revenue in Global Market (2018-2023)
7.8.5 Indian Immunologicals Ltd Key News & Latest Developments
7.9 Heska Corporation
7.9.1 Heska Corporation Company Summary
7.9.2 Heska Corporation Business Overview
7.9.3 Heska Corporation Gene-Deleted Vaccines Major Product Offerings
7.9.4 Heska Corporation Gene-Deleted Vaccines Revenue in Global Market (2018-2023)
7.9.5 Heska Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gene-Deleted Vaccines Market Opportunities & Trends in Global Market
Table 2. Gene-Deleted Vaccines Market Drivers in Global Market
Table 3. Gene-Deleted Vaccines Market Restraints in Global Market
Table 4. Key Players of Gene-Deleted Vaccines in Global Market
Table 5. Top Gene-Deleted Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene-Deleted Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene-Deleted Vaccines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene-Deleted Vaccines Product Type
Table 9. List of Global Tier 1 Gene-Deleted Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene-Deleted Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene-Deleted Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gene-Deleted Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene-Deleted Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Gene-Deleted Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gene-Deleted Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene-Deleted Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Gene-Deleted Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gene-Deleted Vaccines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene-Deleted Vaccines Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene-Deleted Vaccines Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene-Deleted Vaccines Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene-Deleted Vaccines Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene-Deleted Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene-Deleted Vaccines Revenue, (US$, Mn), 2024-2029
Table 30. Virbac SA Company Summary
Table 31. Virbac SA Gene-Deleted Vaccines Product Offerings
Table 32. Virbac SA Gene-Deleted Vaccines Revenue (US$, Mn) & (2018-2023)
Table 33. Virbac SA Key News & Latest Developments
Table 34. Merck Animal Health Company Summary
Table 35. Merck Animal Health Gene-Deleted Vaccines Product Offerings
Table 36. Merck Animal Health Gene-Deleted Vaccines Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Animal Health Key News & Latest Developments
Table 38. Zoetis Inc Company Summary
Table 39. Zoetis Inc Gene-Deleted Vaccines Product Offerings
Table 40. Zoetis Inc Gene-Deleted Vaccines Revenue (US$, Mn) & (2018-2023)
Table 41. Zoetis Inc Key News & Latest Developments
Table 42. Boehringer Ingelheim GmbH Company Summary
Table 43. Boehringer Ingelheim GmbH Gene-Deleted Vaccines Product Offerings
Table 44. Boehringer Ingelheim GmbH Gene-Deleted Vaccines Revenue (US$, Mn) & (2018-2023)
Table 45. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 46. Ceva Company Summary
Table 47. Ceva Gene-Deleted Vaccines Product Offerings
Table 48. Ceva Gene-Deleted Vaccines Revenue (US$, Mn) & (2018-2023)
Table 49. Ceva Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer Gene-Deleted Vaccines Product Offerings
Table 52. Bayer Gene-Deleted Vaccines Revenue (US$, Mn) & (2018-2023)
Table 53. Bayer Key News & Latest Developments
Table 54. Biogenesis-Bago Company Summary
Table 55. Biogenesis-Bago Gene-Deleted Vaccines Product Offerings
Table 56. Biogenesis-Bago Gene-Deleted Vaccines Revenue (US$, Mn) & (2018-2023)
Table 57. Biogenesis-Bago Key News & Latest Developments
Table 58. Indian Immunologicals Ltd Company Summary
Table 59. Indian Immunologicals Ltd Gene-Deleted Vaccines Product Offerings
Table 60. Indian Immunologicals Ltd Gene-Deleted Vaccines Revenue (US$, Mn) & (2018-2023)
Table 61. Indian Immunologicals Ltd Key News & Latest Developments
Table 62. Heska Corporation Company Summary
Table 63. Heska Corporation Gene-Deleted Vaccines Product Offerings
Table 64. Heska Corporation Gene-Deleted Vaccines Revenue (US$, Mn) & (2018-2023)
Table 65. Heska Corporation Key News & Latest Developments
List of Figures
Figure 1. Gene-Deleted Vaccines Segment by Type in 2022
Figure 2. Gene-Deleted Vaccines Segment by Application in 2022
Figure 3. Global Gene-Deleted Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene-Deleted Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gene-Deleted Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene-Deleted Vaccines Revenue in 2022
Figure 8. By Type - Global Gene-Deleted Vaccines Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gene-Deleted Vaccines Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gene-Deleted Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gene-Deleted Vaccines Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gene-Deleted Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gene-Deleted Vaccines Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gene-Deleted Vaccines Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gene-Deleted Vaccines Revenue Market Share, 2018-2029
Figure 16. US Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gene-Deleted Vaccines Revenue Market Share, 2018-2029
Figure 20. Germany Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 21. France Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gene-Deleted Vaccines Revenue Market Share, 2018-2029
Figure 28. China Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. India Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gene-Deleted Vaccines Revenue Market Share, 2018-2029
Figure 34. Brazil Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gene-Deleted Vaccines Revenue Market Share, 2018-2029
Figure 37. Turkey Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gene-Deleted Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. Virbac SA Gene-Deleted Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Animal Health Gene-Deleted Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Zoetis Inc Gene-Deleted Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Boehringer Ingelheim GmbH Gene-Deleted Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Ceva Gene-Deleted Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bayer Gene-Deleted Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Biogenesis-Bago Gene-Deleted Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Indian Immunologicals Ltd Gene-Deleted Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Heska Corporation Gene-Deleted Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
